REVIEW article

Front. Oncol.

Sec. Genitourinary Oncology

Volume 15 - 2025 | doi: 10.3389/fonc.2025.1546835

Research progress of imaging diagnosis and phototherapy based on nanoparticles in prostate cancer: a review

Provisionally accepted
Weihong  ChenWeihong Chen1*Xiaofeng  MaXiaofeng Ma1Lijun  LiangLijun Liang1Xiuling  ZhangXiuling Zhang1Xiaoling  XieXiaoling Xie2*
  • 1Lanzhou University Second Hospital, Lanzhou, China
  • 2First Hospital of Lanzhou University, Lanzhou, Gansu Province, China

The final, formatted version of the article will be published soon.

Prostate cancer (PCa) is a very common disease, ranking second among cancers that cause death in men. Although traditional drugs and surgery can alleviate the rapid development of the disease, the serious side effects limit its further application. Phototherapy including photodynamic therapy (PDT) and photothermal therapy (PTT) has demonstrated distinctive potential in PCa treatment. Under external light irradiation, phototherapy can convert light into heat or produce reactive oxygen species to promote tumor cell necrosis or apoptosis. In addition, some nanomaterials used in phototherapy can realize the synergy of targeted imaging and phototherapy after modification. In this review, we will summarize the application status and future development prospects of phototherapy in prostate cancer.

Keywords: nano-systems, Phototherapy, imaging, Prostatic cancer (Pca), Research progress

Received: 17 Dec 2024; Accepted: 28 Feb 2025.

Copyright: © 2025 Chen, Ma, Liang, Zhang and Xie. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Weihong Chen, Lanzhou University Second Hospital, Lanzhou, China
Xiaoling Xie, First Hospital of Lanzhou University, Lanzhou, Gansu Province, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Research integrity at Frontiers

94% of researchers rate our articles as excellent or good

Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


Find out more